Michel Desjarlais
Montreal, QC H3T1J4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
CRISPR-based chemogenomic profiling reveals redox vulnerabilities to epigallocatechin-3-gallate and green tea polyphenol extract.
Journal: Redox biology
Published: November 14, 2025
Disrupting the TGF-β-regulated epithelial-mesenchymal transition, apoptotic and autophagic phenotypes of 3D glioblastoma spheroids via glycolytic inhibition.
Journal: Exploration of targeted anti-tumor therapy
Published: November 13, 2025
Hypercholesterolemia Impairs the Expression of Angiogenic MicroRNAs in Extracellular Vesicles Within Ischemic Skeletal Muscles.
Journal: Non-coding RNA
Published: November 07, 2025
Role of Cellular Senescence in IUGR: Impact on Fetal Morbidity and Development.
Journal: Cells
Published: May 23, 2025
Evidence for a JAK2/STAT3 proinflammatory and vasculogenic mimicry interrelated molecular signature in adipocyte-derived mesenchymal stromal/stem cells.
Journal: Cell communication and signaling : CCS
Published: April 11, 2025
Novel Function of Nogo-A as Negative Regulator of Endothelial Progenitor Cell Angiogenic Activity: Impact in Oxygen-Induced Retinopathy.
Journal: International journal of molecular sciences
Published: July 24, 2023
Stimulation of soluble guanylate cyclase activity with riociguat promotes angiogenesis and improves neovascularization after limb ischemia.
Journal: Atherosclerosis
Published: June 03, 2022
Tyrosine-Protein Phosphatase Non-receptor Type 9 (PTPN9) Negatively Regulates the Paracrine Vasoprotective Activity of Bone-Marrow Derived Pro-angiogenic Cells: Impact on Vascular Degeneration in Oxygen-Induced Retinopathy.
Journal: Frontiers in cell and developmental biology
Published: March 12, 2021
An allosteric interleukin-1 receptor modulator mitigates inflammation and photoreceptor toxicity in a model of retinal degeneration.
Journal: Journal of neuroinflammation
Published: September 21, 2020
Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
Journal: Frontiers in pharmacology
Published: September 07, 2020
Last Updated: 09/26/2026